Moxetumomab pasudotox-tdfk Intravenous and Prevacid Naprapac
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Prevacid Naprapac and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: lansoprazole / naproxen
Brand name: Prevacid NapraPAC 500
Synonyms: Prevacid NapraPAC
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Prevacid OTC
- Moxetumomab pasudotox-tdfk Intravenous-Prevacid SoluTab
- Moxetumomab pasudotox-tdfk Intravenous-Prevalite
- Moxetumomab pasudotox-tdfk Intravenous-Preven EC
- Moxetumomab pasudotox-tdfk Intravenous-Prevex Hc Topical application
- Moxetumomab pasudotox-tdfk Intravenous-Previfem
- Prevacid Naprapac-Moxifloxacin
- Prevacid Naprapac-Moxifloxacin (Systemic)
- Prevacid Naprapac-Moxifloxacin Hydrochloride
- Prevacid Naprapac-Moxifloxacin Injection
- Prevacid Naprapac-Moxifloxacin Intravenous
- Prevacid Naprapac-Moxifloxacin Tablets